In order to ensure the supply of medicine in short supply, the policy enlarged the recruitment again

[industry trends of pharmaceutical network] on January 15, the national health and Health Commission issued the measures for the administration of the list of drugs in short supply (Trial) (Draft for comments) According to the draft for comments, in order to strengthen the early warning of drug shortage risk, the state will focus on monitoring the clinically necessary and vulnerable drugs At the same time, drugs that are available for market supply, which can form effective competition and meet clinical needs basically, can be replaced by new drugs with better risk efficiency ratio or cost-effectiveness ratio In addition, it is worth noting that the draft also makes it clear that for the varieties in the national and provincial list of drugs in short supply, enterprises are allowed to quote independently on the provincial drug centralized procurement platform, directly link to the Internet, and medical institutions are allowed to purchase independently In fact, it also gives a "reassuring pill" to the relevant pharmaceutical enterprises, which not only guarantees the independent pricing power of the relevant pharmaceutical enterprises, enables them to have sufficient production power, but also strictly prevents profiteering, price monopoly and other behaviors, or will solve the current shortage of drug supply dilemma, to a greater extent, benefiting the people's livelihood   It is understood that the purpose of the draft is to strengthen the supply guarantee of national drugs in short supply, establish and improve the management system of the list of drugs in short supply, do a good job in the management of the list of drugs in short supply, lay the foundation for the formulation, release and adjustment of the list of national drugs in short supply and the list of key monitoring drugs in clinical necessity, and organize the management of the list of drugs in short supply Method formulation In fact, in recent years, the shortage of drugs in China has been concerned The reason lies in the guarantee mechanism of the shortage of drugs, which is related to the safety of every patient Once the supply of drugs is cut off, the consequences will be unimaginable Therefore, the state has been trying to take measures to ensure the supply of medicines in short supply For example, in October 2019, the relevant departments issued the opinions on further ensuring the supply and price stability of drugs in short supply, which regulated a series of issues, aiming at ensuring the basic drug demand of the masses Among them, it is also clearly proposed to build a national multi-source information collection platform for drugs in short supply and manage the list of drugs in short supply In addition to the state has been taking safeguard measures for the supply of short drugs, all regions are also further improving the relevant work of the safeguard mechanism for the supply of short drugs For example, on November 8, 2019, Heilongjiang Medical Security Bureau issued the notice on further ensuring the supply and price stability of drugs in short supply, which requires strengthening the normal supervision of drug prices According to the monitoring results, cost investigation should be carried out or commissioned for drugs with abnormal price increase or frequency and large price difference among regions In addition, it is also proposed that for the varieties in the national and provincial drug shortage list, the manufacturer can apply for direct Internet access, independent quotation, and independent price negotiation and procurement between medical institutions and manufacturers Recently, the general office of Jiangxi provincial government also issued the division of tasks for the work of ensuring supply and price stability of short drugs in Jiangxi Province, and 14 departments jointly issued the notice on improving the consultation and linkage mechanism for the work of ensuring supply and price of short drugs in Jiangxi Province to jointly promote the construction of the consultation and linkage mechanism for the work of ensuring supply and price of short drugs It is understood that Jiangxi will take comprehensive measures in four aspects: organizational guarantee, monitoring and early warning, disposal response, and supervision and law enforcement For example, for drug manufacturers participating in the centralized purchase of drugs in the whole province, the platform shall be shut down 30 days in advance for the expected varieties that cannot be produced and supplied normally In view of the current situation, the National Health Insurance Bureau will establish a sound long-term regulatory mechanism to deal with the rapid rise of drug prices In the future, or will continue to deepen the reform of the centralized drug purchase mechanism, accelerate the pilot of centralized drug purchase and use organized by the state, and establish credit evaluation and incentive and disciplinary measures for price and bidding procurement.